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The molecular clock protein Bmal1 regulates cell
differentiation in mouse embryonic stem cells
Amador Gallardo1,2,3, Aldara Molina1,2,3, Helena G Asenjo1,2,3, Jordi Martorell-Marugán1,4 , Rosa Montes1,
Verónica Ramos-Mejia1 , Antonio Sanchez-Pozo1,2 , Pedro Carmona-Sáez1,6 , Lourdes Lopez-Onieva1,5,
David Landeira1,2,3
Mammals optimize their physiology to the light–dark cycle by
synchronization of the master circadian clock in the brain with
peripheral clocks in the rest of the tissues of the body. Circadian
oscillations rely on a negative feedback loop exerted by the
molecular clock that is composed by transcriptional activators
Bmal1 and Clock, and their negative regulators Period and
Cryptochrome. Components of the molecular clock are expressed
during early development, but onset of robust circadian oscilla-
tions is only detected later during embryogenesis. Here, we have
used naı̈ve pluripotent mouse embryonic stem cells (mESCs) to
study the role of Bmal1 during early development. We found that,
compared to wild-type cells, Bmal12/2 mESCs express higher
levels of Nanog protein and altered expression of pluripotency-
associated signalling pathways. Importantly, Bmal12/2 mESCs
display deficient multi-lineage cell differentiation capacity during
the formation of teratomas and gastrula-like organoids. Overall, we
reveal that Bmal1 regulates pluripotent cell differentiation and
propose that the molecular clock is an hitherto unrecognized
regulator of mammalian development.
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Introduction
The earth rotates around its own axis with a 24-h period that
generates repetitive changes in the intensity of sunlight reaching
our planet. Organisms that live on the surface of the earth have
developed mechanisms to optimize their physiology to this
light–dark cycle. Circadian pacemakers allow to carry out an ap-
proximate measurement of time, so their phase must be adjusted
daily to keep the internal clock in perfect synchrony with external
signals. The main circadian synchronizer in mammals is light that is
received in specialized photoreceptor cells in the retina, and the
information is transmitted directly to the suprachiasmatic nucleus
in the brain that synchronizes peripheral clocks through humoral
signals such as hormones (Dibner et al, 2010). Most of cells of the
adult organism have their own internal clock that needs to be
synchronized to be in the same circadian phase as the rest of the
body and, therefore, facilitate optimal physiological functioning
(Mohawk et al, 2012). Circadian regulation relies on the activity of
the molecular clock that mediates the establishment of an
autoregulatory loop that generates daily oscillations in the ex-
pression of target genes (Takahashi, 2017). This machinery is
composed by the core Clock and Bmal1 (also known as Arntl, aryl
hydrocarbon receptor nuclear translocator-like) heterodimer that
activates transcription of their own negative regulators Period
(Per1, Per2, and Per3) and Cryptochrome (Cry1 and Cry2) genes. The
molecular clock can regulate up to 10% of cellular transcripts in a
tissue-specific way (Storch et al, 2002; Masri & Sassone-Corsi, 2010).
The function of the molecular clock during mammalian embryonic
development is poorly understood (Seron-Ferre et al, 2012; Landgraf
et al, 2014). Some components of the molecular clock are expressed
during embryo development, but they do not generate consistent
circadian fluctuations in embryo tissues until late stages of devel-
opment when the suprachiasmatic nucleus is formed and the embryo
is exposed to sunlight (Seron-Ferre et al, 2012; Landgraf et al, 2014;
Umemura et al, 2017). In agreement, germline cells, zygotes, preim-
plantation embryos, and mouse embryonic stem cells (mESCs) de-
rived from the developing blastocyst express components of the
molecular clock but do not display circadian oscillations (Alvarez
et al, 2003; Morse et al, 2003; Amano et al, 2009; Yagita et al, 2010).
Importantly, despite mutant embryos lacking Bmal1 or other com-
ponents of themolecular clock proceed through embryogenesis with
no apparent phenotype at birth (van der Horst et al, 1999; Zheng et al,
2001; Kondratov et al, 2006; DeBruyne et al, 2007), recent evidence
highlights that the lack of Bmal1 during embryo development is
responsible for reduced life span, body weight, and fertility observed
during the adult life in Bmal1−/− mice (Yang et al, 2016).
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In this study, we have used naı̈ve mESCs as a model system to
analyse the molecular function of Bmal1 during early mouse de-
velopment. We found that Bmal1−/− mESCs are viable and express
pluripotency-associated markers. Bmal1−/− mESCs display in-
creased expression of the pluripotency factor Nanog coupled to the
mis-regulation of pluripotency signalling pathways. Importantly, the
lack of Bmal1 protein in mESCs does not block pluripotency exit but
perturbs the execution of multi-lineage cell differentiation as
assayed using in vivo and in vitro cell differentiation systems. Our
observations reveal a novel role of Bmal1−/− in the regulation of
pluripotent cell differentiation and suggest that components of the
molecular clock regulate mammalian development through molec-
ular mechanisms that remain to be characterized.
Results
Bmal1 is expressed in pluripotent cells
mESCs do not show circadian oscillation of clock genes, but these
can be induced by in vitro differentiation towards mouse neural
stem cells (mNSCs) (Yagita et al, 2010). Reciprocally, circadian os-
cillations in mNSCs are extinguished when they are artificially
reprogrammed to pluripotency (Yagita et al, 2010). We asked
whether the onset of circadian oscillations during mESCs differ-
entiation was associated with differences in Bmal1 expression
levels. Colonies of mESCs growing in FBS and leukemia inhibitory
factor (LIF) (mESCs FBS + LIF or primed serum mESCs) were dif-
ferentiated into mNSCs that showed the typical fusiform shape
morphology and grew as a reticular network (Fig 1A). mNSC cultures
showed expected down-regulation of pluripotency genes Nanog,
Oct4, and Rex1 coupled to up-regulation of mNSC genes Fabp7,
Slc1a3, and Nestin (Fig 1B). Immunofluorescence analysis con-
firmed that NSC cultures do not express the nuclear pluripotency-
associated transcription factor Oct4 and showed homogeneous
staining of the NSC protein marker Nestin in their cytoplasms (Fig
1C). Comparison of mRNA expression level in primed serum mESCs
and NSCs showed that Bmal1 is expressed at a similar level in both
cell types (Fig 1D). Expression of Bmal1 was similar to the tran-
scriptionally active housekeeping gene Hmbs, indicating that Bmal1
is expressed at functional levels in mESCs (Fig 1D). Western blot
analysis using anti-Bmal1 antibodies revealed two bands at 71 kD
that correspond to previously described phosphorylated and
unphosphorylated isoforms of Bmal1 (Yoshitane et al, 2009; Sahar
et al, 2010) in mNSCs (Fig 1E). Importantly, primed serummESCs and
mNSCs expressed similar levels of Bmal1 protein (Figs 1E and S1A),
suggesting that Bmal1 might be functional in pluripotent cells.
To discard that expression of Bmal1 protein was associated to
marginal spontaneous cell differentiation and cell heterogeneity
typically found in primed serummESC cultures (Li & Izpisua Belmonte,
2018), we analysed expression of Bmal1 in naı̈ve pluripotent cells.
Primed serum mESCs were transferred to defined media with LIF and
inhibitors of MAPK and glycogen synthase kinase 3 (2i + LIF media), to
establish cultures of naı̈ve 2i pluripotent cells (Ying et al, 2008). Ex-
pression of Bmal1was similar and slightly increased in naı̈ve 2i mESCs
as comparedwith primed serummESCs, at the level of bothmRNA and
protein (Figs 1F and G and S1B), further indicating that Bmal1 is
expressed at a functional level in pluripotent cells. To confirm that
expression of Bmal1 in pluripotent mESCs is not an artefact of in vitro
cell culture conditions, we analysed whether Bmal1 is also transcribed
in pluripotent cells in vivo. We interrogated published single-cell
messenger RNA high-throughput sequencing (mRNA-seq) datasets
of developing preimplantation embryos (Deng et al, 2014) and found a
heterogeneous pattern of Bmal1 expression at all stages from four
cells to late blastocyst (Fig 1H). Importantly, cells that express a higher
level of the pluripotency gene Oct4 also tend to express higher levels
of Bmal1 mRNA at the blastocyst stage (Fig 1I), demonstrating that
Bmal1 mRNA is expressed in pluripotent cells in vivo.
Last, cell fractionation followed by Western blot experiments
showed that distribution of Bmal1 protein in mESCs is similar to its
distribution in NSCs (nucleus and cytoplasm) (Figs 1J and S1C),
suggesting that the absence of circadian oscillations in ESCs is not a
consequence of the exclusion of Bmal1 from the nucleus of plu-
ripotent cells. Taken together, these results solidly demonstrate that
albeit mESCs do now display circadian oscillations (Yagita et al, 2010),
the molecular clock protein Bmal1 is present in pluripotent cells.
Bmal12/2 mESCs remain undifferentiated and express a higher
level of Nanog protein
To investigate the role of Bmal1 protein in pluripotent cells, we derived
Bmal1−/− mESCs using CRISPR/Cas9 and grew them in the 2i + LIF
medium. The amino terminus of Bmal1 was targeted (exon 5) (Fig 2A),
and a panel of genetic clonalmESC lines were screened and genotyped.
The frequency of Bmal1 mutants in one or both alleles was high (four
heterozygous [Bmal1+/−] and four compound heterozygous [Bmal1−/−]
mutants of 12 screened clonal colonies), suggesting that Bmal1 is not
essential to establish undifferentiated mESC cultures. Of the four
Bmal1−/− clonal cell lines, we focused on one in which both alleles
contained DNA indel mutations (−22 and +61 nucleotides, respectively)
at expected target sites (Fig 2B) and resulted in frame shifts and pre-
mature stop codons at the very beginning of Bmal1 open reading frame,
impeding the production of peptides that include any of the annotated
functional domains included in Bmal1 protein (BHLH, PAS1, PAS2, and
TAD).Bmal1−/−mESCs formed typically tight three-dimensional colonies
similar to the ones generated by parental wild-type cells (Fig 2C). As
expected, expression of Bmal1 mRNA was not detected in Bmal1−/−
mESCs comparedwith wild-type cells (Fig 2D), andWestern blot analysis
indicated that Bmal1−/− mESCs do not express detectable levels of
Bmal1 protein (Fig 2E). Bmal1−/− mESC cultures remain undifferen-
tiated because they retained expression of pluripotency-associated
transcription factors Oct4, Nanog, and Rex1 (Fig 2F). Interestingly, we
found that Bmal1−/− mESCs express even higher levels of Nanog
mRNA and protein than parental wild-type cells (Figs 2F–I and S1D).
Taken together, these results demonstrate that Bmal1 protein is not
essential for mESCs self-renewal, and that its depletion results in up-
regulation of Nanog expression in naı̈ve 2i mESCs.
Bmal12/2 mESCs display altered expression of signalling
pathway genes and cell differentiation potential
To further understand the role of Bmal1 in pluripotent cells, we
compared mRNA expression in Bmal1−/− and wild-type naı̈ve 2i
mESCs by mRNA-seq. 854 gene transcripts were differentially
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Figure 1. Bmal1 is expressed in pluripotent cells.
(A)Microscopic images of JM8 wild-type mouse embryonic stem cells (mESCs) and in vitro–derived mouse neural stem cell (mNSC) cultures. Scale bar is 100 μm. (B) RT-
qPCR analysis of pluripotency-associated genes (Nanog,Oct4, and Rex1) and neural stem cell genemarkers (Fabp7, Slc1a3, andNestin) inmESCs andmNSCs. Expression is
normalized to Gapdh and RNA18s. (C) Immunofluorescence images showing the expression of pluripotency (Oct4, green) and NSC (Nestin, green) protein markers in mESC
and mNSC cultures. DAPI stains nuclear DNA (blue). Scale bar is 10 μm. (D) Expression of Bmal1 in mESCs and NSCs measured by RT-qPCR. Expression of Hmbs was
included as a control of a transcriptionally active and functional gene. Expression was normalized to Gapdh and RNA18s and multiplied by 10 to facilitate representation.
(E) Western blot analysis of whole-cell extracts comparing Bmal1 protein levels in mESCs and mNSCs. B-actin provides a loading control. (F) RT-qPCR analysis comparing
expression of Bmal1 in mESCs grown in FBS + LIF or 2i + LIF media. Expression was normalized to Gapdh and RNA18s and multiplied by 10 to facilitate representation.
(G) Western blot analysis of whole-cell extracts comparing Bmal1 protein levels in mESCs grown in FBS + LIF and 2i + LIF media. B-actin provides a loading control.
(H) Single-cell mRNA expression values of Bmal1 during indicated stages of preimplantation development calculated using previously published datasets (Deng et al, 2014).
(I) Analysis of Bmal1 expression inOct4 low and high individual cells during the blastocyst stage (early, mid, and late). Mean and SEM is shown. (J)Western blot analysis of
Bmal1 protein localization in cell fractionation analysis of mESCs and mNSCs. Cytoplasmic (C) and nuclear (N) fractions are indicated. Ezh2 was used as a nuclear control.
(B, D, F) Mean and SEM of three independent experiments are shown in (B, D, F). (B, I) Asterisks (*) in (B, I) indicate significant difference (t-Student P < 0.05).
Bmal1 regulates cell differentiation Gallardo et al. https://doi.org/10.26508/lsa.201900535 vol 3 | no 5 | e201900535 3 of 12
expressed (up- or down-regulated by more than twofold and ad-
justed P-value < 0.05) in cells that lack Bmal1 as compared with
parental wild-type cells (Fig 3A). Unexpectedly, 689 of these tran-
scripts (80.6%) were up-regulated in Bmal1−/− cells, suggesting
that, in contrast to the role of Bmal1 in promoting transcription of
target genes in adult tissues (Takahashi, 2017), Bmal1 is not acting as
a transcriptional activator in pluripotent mESCs. Most of the up-
regulated genes in Bmal1−/− mESCs were already transcriptionally
active in wild-type cells (Fig 3B), suggesting that Bmal1 negatively
modulates transcription of active genes. Functional categories
analysis revealed that Bmal1−/− mESCs display mis-regulation of
genes encoding for 180 glycoproteins and 59 developmental pro-
teins, suggesting that Bmal1 is involved in the regulation of cell
communication and development (Fig 3C). In fitting, gene ontology
analysis showed that depletion of Bmal1 results in deregulation of
genes involved in cell differentiation and organism development
(Fig 3D), and pathway enrichment analysis exposed that Bmal1−/−
mESCs display altered regulation of pluripotency-associated sig-
nalling pathways including phosphoinositide 3-kinase (PI3K), MAPK,
and Wnt (Fig 3E). In agreement with the general trend towards
Figure 2. Bmal12/2 mouse embryonic stem cells (mESCs) remain undifferentiated and express higher level of Nanog protein than wild-type cells.
(A) Scheme of the Bmal1 gene (black bars, exons) and the CRISPR/Cas9 strategy used. DNA sequence targeted by the guide RNA (red) and the localization of the PAM
domain (blue) are indicated. (B) Alignment of DNA sequences of the Bmal1 gene upon genotyping of Bmal1−/−mESCs obtained using CRISPR/Cas9. DNA regions targeted
by the guide RNA are indicated in red. (C) Microscopy images of Bmal1−/− and wild-type mESCs grown in the 2i + LIF medium. Scale bar is 100 μm. (D) RT-qPCR analysis of
Bmal1 mRNA in wild-type and Bmal1−/− mESCs. ActB was used as a housekeeping control. Expression was normalized to Gapdh and RNA18s and multiplied by 10 for
better representation. n.d. indicates non-detection of transcripts. Mean and SEM of three independent experiments is shown. (E) Western blot analysis of Bmal1 protein
using whole-cell extracts of Bmal1−/− and wild-type mESCs. Lamin B provides a loading control. (F) mRNA expression analysis of Nanog, Oct4, and Rex1 in Bmal1−/− and
wild-type mESCs by RT-qPCR. Expression was normalized to Gapdh and RNA18s and multiplied by 10 for better representation. Asterisk (*) indicates significant
difference (T-student P < 0.05). (G)Western blot analysis of whole-cell extracts comparing the protein levels of Nanog and Oct4 in Bmal1−/− and wild-typemESCs. Lamin B
was used as a loading control. (H) Immunofluorescence analysis of Nanog protein (green) expression in Bmal1−/− and wild-type mESCs. DAPI stains nuclear DNA (blue).
Scale bar is 10 μm. (I) Histogram showing the percentage of cells with low or high intensity of Nanog staining in parental and Bmal1−/−mESCs. Mean and SEM of three
independent experiments is shown. Asterisks (*) indicate significant difference (Fisher’s test, P < 0.01).
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Figure 3. Bmal12/2 mouse embryonic stem cells (mESCs) display altered expression of pluripotency signalling pathways and differentiation potential.
(A) Gene expression analysis by mRNA-seq of Bmal1−/− and parental wild-type mESCs grown in the 2i + LIF medium using heat map clustering. Red and blue indicates
higher and lower expression, respectively. Biological duplicates (R1 and R2) were carried out for indicated genotypes. (B) MA plot analysis of deregulated genes in Bmal1−/−
mESCs. y-axis indicates fold change expression between Bmal1−/− and parental mESCs, whereas x-axis shows the mean expression level. Each dot represents one gene.
Significantly mis-regulated genes are plotted in red. (C, D, E) Gene enrichment analyses of mis-regulated genes (854 genes with FC > 2 and P < 0.05) in Bmal1−/−mESCs.
Categories are sorted by P-value and the number of genes included in each term are indicated in the x-axis. (F) Comparative expression analysis in Bmal1−/− and
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up-regulation of gene transcripts found in Bmal1−/− mESCs, most
differentially expressed genes involved in cell differentiation and
embryo development were up-regulated in these cells (i.e., 47 of
58 genes involved in development, Fig S2A). In addition, analysis of
components of signalling pathways deregulated in Bmal1−/−
mESCs confirmed widespread abnormal expression patterns of
mRNA transcripts involved in pluripotency signalling and cell
differentiation including the MAPK pathway (Figs 3F and S2B). MAPK
pathway, also known as extracellular signal-regulated kinases
(Erk1/2) pathway, inhibits Nanog expression in mESCs (Wray et al,
2010), and thus, we wondered whether deregulation of this pathway
underlie the up-regulation of Nanog protein found in Bmal1−/−
mESCs (Fig 2F–I). However, expression of Erk1/2 protein was un-
altered in Bmal1−/− mESCs in both primed serum and naı̈ve 2i
conditions (Fig S2C), and mRNA expression of Erk1/2 targets
(Hamilton & Brickman, 2014) was not affected by depletion of Bmal1
protein (Fig S2D and E), suggesting that up-regulation of Nanog
protein is not a consequence of reduced Erk1/2 signalling in
Bmal1−/− mESCs.
We reasoned that up-regulation of Nanog protein and mis-
regulation of signalling components might hinder the multi-
lineage differentiation capacity of Bmal1−/− mESCs. We injected
Bmal1−/− and wild-type mESCs into immunodeficient mice and
assayed their ability to form teratomas and differentiate into the
three germ layers. As expected, imaging analysis of teratomas using
haematoxylin and eosin staining confirmed that wild-type mESCs
can differentiate into tissues derived from the three germ layers.
For example, we could detect skin (ectoderm), glandular tissue
(endoderm), and smooth muscle (mesoderm) (Fig 3G). Bmal1−/−
teratomas also contained tissues derived from the three germ
layers, suggesting that the lack of Bmal1 does not fully block dif-
ferentiation towards any the of three germ layers in vivo (Fig 3G). To
complement this analysis using a quantitative approach, we
performed immunohistochemistry using antibodies against glial
fibrillary acidic protein (Gfap), cytokeratin, and smoothmuscle actin
that are well-established markers of ectoderm, endoderm, and
mesoderm tissue respectively. Importantly, teratomas formed by
Bmal1−/− cells displayed reduced labelling for Gfap, cytokeratin,
and smoothmuscle actinmarkers compared withwild-type cells (Fig
3H and I), indicating that although Bmal1−/− cells can produce tissue
derived from the three germ layers, their differentiation potential is
altered compared with wild-type cells.
We wondered whether reduced differentiation capability of
Bmal1−/− mESCs was a consequence of abnormal expression
of lineage specifier genes before teratoma formation. Analysis
of mRNA expression of a subset of master regulators of ectoderm
(Sox1, Wnt7b, Pcdh17, Gsx1, and Pax6), endoderm (Gata4, Gata6,
Foxa2, Cxcr4, and Sox7), and mesoderm (Bry, Bmp2, Hand1, Eomes,
Mixl1, and Bmp4) lineages showed that Bmal1−/− mESCs retain
repression of lineage specifier genes (Fig S2F and G). This suggests
that differentiation defects found in Bmal1−/− teratomas are not a
consequence of unscheduled transition of Bmal1−/− mESCs into a
differentiated state, but rather mis-regulation of lineage specifier
gene activation upon induction of cell differentiation.
Bmal1 modulates multi-lineage differentiation in pluripotent
cells
We compared the dynamics of lineage transition of Bmal1−/− and
wild-type mESCs at early time points during cell differentiation
using well-established in vitro systems. We induced cell differenti-
ation by plating naı̈ve 2i mESCs in N2B27 media growing as adherent
cultures (Ying et al, 2003) and compared down-regulation of plu-
ripotency genes and activation of differentiation markers by RT-qPCR
in Bmal1−/− and parental wild-type cells (Fig 4A). As expected, wild-
type cells down-regulated pluripotency genes (Oct4 andNanog; black
bars) and induced expression of ectoderm (Sox1,Wnt7b, Pcdh17, Gsx1,
and Pax6; blue bars), endoderm (Gata4, Gata6, Bmp2, Cxcr4, and Sox7;
green bars), and mesoderm (Bmp2, Hand1, Msx2, Eomes, Bmp4, and
Mixl1; red bars) genes after 4 d of differentiation (Figs 4B and C and
S3A). Likewise, Bmal1−/− mESCs also down-regulated pluripotency
genes and activated ectoderm genes (Figs 4B and C and S3A).
However, activation of endoderm and mesoderm markers was se-
verely hindered in differentiating Bmal1−/− cells (grey bars), as
compared with wild-type control cells (Figs 4C and S3A).
To confirm that Bmal1 is required for activation of endoderm and
mesoderm genes during pluripotent cell differentiation, we com-
pared early time points upon pluripotency exit in primed serum
Bmal1−/− and wild-typemESCs growing as adherent cultures (Fig 4D).
Bmal1−/− mESCs down-regulated the pluripotency gene Nanog (Fig
4E) and induced expression of ectoderm markers (Sox1, Gsx1, and
Pax6) with similar kinetics to wild-type mESCs (Fig 4F). Importantly,
primed serum Bmal1−/− mESCs showed hindered activation of
endoderm (Gata4, Gata6, Foxa2, Cxcr4, and Sox7) and mesoderm
markers (Bmp2, Hand1, andMsx2) (Figs 4F and S3B). Taken together,
these results indicate that Bmal1 is required to modulate multi-
lineage differentiation in pluripotent mESCs and indicate that its
activity favours endoderm and mesoderm specification.
Bmal1 is required for the formation of gastrula-like organoids
To further examine the altered differentiation capacity of Bmal1−/−
mESCs, we analysed their ability to differentiate and produce
gastrula-like organoids (gastruloids) in vitro (Beccari et al, 2018).
Bmal1−/− and wild-type mESCs were plated in low-attachment
conditions to induce the formation of gastruloids, and their mor-
phology and gene expression profile was compared during 5 d of
differentiation. Compared with wild-type mESCs, Bmal1−/− cells
formed smaller (average diameter on day 5 in wild-type is 371 ± 40 μm
compared with Bmal1−/− 160 ± 16 μm) and less dense-looking
wild-typemESCs of genes involved in pluripotency, PI3K, andMAPK signalling pathways using heat map clustering. (G) Representative images of haematoxylin and eosin
staining of teratomas derived fromwild-type and Bmal1−/−mESCs. Tissues corresponding to three germ layers are shown (black arrow): skin for ectoderm, glandular tissue
for endoderm, and smooth muscle for mesoderm. Scale bar is 100 μm. (H) Representative images of immunohistochemistry analysis of teratomas derived from wild-type
and Bmal1−/−mESCs. Antibodies against Glial fibrillary acidic protein (ectodermmarker), cytokeratin (endodermmarker), and smoothmuscle actin (mesodermmarker)
were used. Scale bar is 500 μm. (H, I) Histogram showing quantification of the area of the images positive for indicated antibodies in teratoma immunohistochemistry
analysis in (H). Mean and SEM of the analysis of 10 images are shown. Asterisk (*) indicates significant difference (t-Student < 0.05).
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Figure 4. Bmal12/2 mouse embryonic stem cells (mESCs) display reduced induction of endoderm and mesoderm genes during monolayer cell differentiation.
(A, B, C) Scheme of the protocol used to analyse differentiation of naı̈ve pluripotent cells in (B, C). (B, C) mRNA expression of pluripotency (black), ectoderm (blue),
endoderm (green), and mesoderm (red) specific genes, at indicated days during differentiation as measure by RT-qPCR in JM8 wild-type and Bmal1−/− (grey) mESCs.
Expression was normalized to housekeeping genes Hmbs and Ywhaz. Fold change relative to time 0 is represented. (D, E, F) Scheme of the protocol used to analyse
differentiation of primed serum pluripotent cells in (E, F). (E, F)mRNA expression of pluripotency (black)-, ectoderm (blue)-, endoderm (green)-, and mesoderm (red)-
specific genes at indicated days during differentiation as ameasure by RT-qPCR in JM8 wild-type and Bmal1−/− (grey) mESCs. Expression was normalized to housekeeping
genes Hmbs and Ywhaz. Fold change relative to time 0 is represented. (B, C, E, F) Mean and SEM of three independent experiments are shown in (B, C, E, F). (B, C, E, F)
Asterisks (*) in (B, C, E, F) indicate significant difference (T-student P < 0.05) between Bmal1−/− and JM8 parental cells at the same time point.
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three-dimensional structures during the course of the experiment
(Fig 5A, white arrows). Analysis of mRNA expression revealed that
differentiating Bmal1−/− mESCs down-regulated pluripotency
genes (Oct4 and Nanog) and induced the activation of ectoderm
genes (Sox1, Gsx1,Wnt7, and Pax6) at a similar or evenmore accused
rate than parental control cells (Figs 5B and C and S3C). In contrast,
Bmal1−/− differentiating gastruloids showed minor induction of
endoderm (Gata4, Gata6, and Foxa2) and mesoderm (Bmp2, Msx2,
and Mixl1) genes compared with parental control cells (Figs 5D and
E and S3C). Thus, we concluded that Bmal1−/− mESCs consistently
fail to activate endoderm and mesoderm genes upon pluripotency
exit in all cell differentiation systems tested.
To confirm that the phenotype of Bmal1−/− mESCs is a conse-
quence of Bmal1 protein depletion and is not linked to a CRISPR/
Cas9 off-target effect, we derived an independent clonal population
of Bmal1−/− mESCs (clone #G10). Genotyping confirmed that these
cells are homozygous mutant for a deletion of four nucleotides in
exon 5 in both alleles of the Bmal1 gene that result in a frameshift
and premature stop codon at the beginning of the open reading
frame (Fig S4A). Bmal1−/− (clone #G10) did not express detectable
levels of Bmal1 protein (Fig 5F), and similarly to the previously
characterized Bmal1−/− mutant (Fig 2), Bmal1−/− (clone #G10)
grown in the 2i + LIFmedium formed typical tight three-dimensional
colonies (Fig S4B) and expressed normal, or slightly increased,
levels of the pluripotency-associated transcription factors Nanog,
Oct4, and Rex1 (Fig 5G). Importantly, Bmal1−/− (clone #G10) mESCs
also displayed higher levels of Nanog protein than wild-type pa-
rental controls (Fig 5H) phenocopying the previous Bmal1−/− cells.
In addition, analysis of the differentiation potential of Bmal1−/−
(clone #G10) further confirmed that the lack of Bmal1 protein results
in the formation of smaller gastruloids (Figs 5I and S4C) that can
down-regulate pluripotency markers and up-regulate ectoderm
genes but have compromised induction of endoderm and meso-
derm markers (Figs 5J and S4D). Taken together, these analyses
confirm that Bmal1 regulates Nanog expression and the multi-
lineage potential of pluripotent cells and suggest that Bmal1 is
required for formation of endoderm and mesoderm tissue during
embryo development.
Discussion
The most important discovery in this study is that the molecular
clock protein Bmal1 is required for correct multi-lineage cell dif-
ferentiation in pluripotent cells. This finding is interesting for the
fields of circadian biology and pluripotency. It is currently not clear
whether circadian proteins are expressed or not in pluripotent cells
(Lu et al, 2016; Umemura et al, 2017), and therefore, our study is
important to establish that the core component of the molecular
clock Bmal1 is expressed in mESCs and that it has a functional role.
Complementarily, our study show that circadian proteins are novel
regulators of pluripotent biology and cell differentiation.
We show that Bmal1 regulates cell differentiation in mESCs
where circadian rhythms cannot be detected using standard ap-
proaches (Kowalska et al, 2010; Yagita et al, 2010). Thus, our study
support that during early development, the molecular clock carries
out a novel and uncharacterized molecular function that does not
rely in the canonical oscillatory production of gene transcripts.
Therefore, an important question that arises from our study is what
is the molecular function of Bmal1 in mESCs and whether it is
carried out in coordination with the rest of the machinery of the
molecular clock. Although there is evidence supporting the absence
of circadian oscillations in pluripotent cells (Kowalska et al, 2010;
Yagita et al, 2010), it is not clear whether the lack of circadian
rhythms is a consequence of the absence of Clock protein; con-
flicting reports show that Clock protein is present (Lu et al, 2016) or
degraded by posttranslational mechanisms (Umemura et al, 2017) in
mESCs. Although this study cannot solve this discrepancy, our results
indicate that the function of Bmal1 in mESCs might be different from
the typical transcriptional regulation exerted in coordination with
Clock in other tissues because depletion of Bmal1 in mESCs leads to
up-regulation of gene transcripts, suggesting Bmal1 is unexpectedly
acting as a transcriptional repressor. Further studies will be needed
to address this important aspect and clarify what is the molecular
function of Bmal1 in the regulation of pluripotency.
Mice lacking Bmal1 from conception are viable and show a pleio-
tropic phenotype including loss of circadian rhythms, an acceleration
of aging, and shortened life span (Bunger et al, 2000; Kondratov et al,
2006). Strikingly, a current report by the FitzGerald Lab shows thatmost
of this phenotype is a consequence of the function of Bmal1 during
embryodevelopment (Yang et al, 2016). Ourfindingsmight help explain
these interesting observations. Bmal1−/−mESCs do not show a severe
block in cell differentiation, but instead they show milder defects that
result in unbalanced regulation of lineage choice during cell differ-
entiation. This type of defects during early embryo development
might allow the formation of viable newborns in Bmal1−/− mice that
accumulate widespreadminor developmental defects that will cause
tissue misfunctioning during adult life, in agreement with reported
phenotypes in life span, fertility, body weight, blood glucose and
arthropathy, atherosclerosis, and hair growth (Kondratov et al, 2006;
Yang et al, 2016). In this context, it is important to note that given that
the differentiation phenotype of Bmal1−/− mESCs is associated to
altered cell signalling, it is likely that developmental defects observed
in our in vitro differentiation systems are partially ameliorated during
embryo development because of compensatorymechanism that take
place in vivo and, thus, facilitate full gestation of Bmal1−/− mice.
In summary, our study provides solid proof that the core mo-
lecular clock component Bmal1 is expressed in pluripotent cells
and that it regulates pluripotent cell differentiation. This suggests
the existence of an uncharacterized function of the molecular clock
that is essential for pluripotency execution and proper embryo
development in mammals. Similar conclusions were drawn from an
independently performed study, which recently came to our at-
tention (Ameneiro et al, 2020).
Materials and Methods
mESC culture and differentiation
JM8 mESCs derived from the mouse strain C57BL6/N were cultured
in primed serum conditions as previously described (Landeira et al,
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Figure 5. Bmal12/2 mouse embryonic stem cells (mESCs) display altered formation of gastrula-like organoids.
(A) Microscopic images of Bmal1−/− and JM8 wild-type mESCs during differentiation into gastruloids at indicated time points. White arrows indicate the position of the
developing gastruloid. Scale bar is 50 μm. Histogram shows the average diameter of wild-type and Bmal1−/− gastruloids on day five. (B, C, D, E) mRNA expression of
pluripotency (black)-, ectoderm (blue)-, endoderm (green)-, and mesoderm (red)-specific genes at indicated days during gastruloid formation as measure by RT-qPCR in
JM8 wild-type and Bmal1−/− (grey) mESCs. Expression was normalized to Hmbs and Ywhaz. Fold change relative to undifferentiated cells at time cero is represented. (F)
Western blot analysis of Bmal1 protein using whole-cell extracts of Bmal1−/− (clone #G10) and wildtype mESCs. B-actin provide a loading control. (G) mRNA expression
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2015); DMEM KO (Gibco) media supplemented with 10% FCS (Gibco),
LIF, penicillin/streptomycin (Gibco), L-glutamine (Gibco), and 2-
mercaptoethanol (Gibco). Ground-state 2i mESCs were grown in
serum-free 2i media as described previously (Ying et al, 2008):
N2B27 supplemented with MEK inhibitor PD0325901 (1 μM) (Milli-
pore) and GSK3 inhibitor CHIR99021 (3 μM) (Millipore) in the
presence of LIF. Both serum-grown and 2i-grown mESCs were
cultured feeder free on 0.1% gelatin-coated dishes at 37°C and 5%
CO2.
Neural stem cell cultures were derived from primed serum JM8
mESCs as previously described (Conti et al, 2005). Ground-state 2i
JM8 and Bmal1−/− cells (1 × 105 cells in six well plates) were dif-
ferentiated as a monolayer as described previously (Ying et al,
2003). JM8 and Bmal1−/− cells growing in serum (12,500 cells/cm2)
were differentiated by LIF removal as a monolayer as previously
described (Landeira et al, 2010). Primed serum JM8 and Bmal1−/−
cells (1 × 104 cells/ml) were induced to form gastrula-like organoids
(gastruloids) as described elsewhere (Beccari et al, 2018).
Teratoma formation and analysis
Onemillion cells of each cell line were resuspended in 250 μl of PBS
and injected subcutaneously into the flanks of NOD/SCID IL-2Rγ−/−
mice in the animal experimentation unit of the University of
Granada. 5 wk later, the mice developed tumours that were re-
moved, rinsed with PBS, fixed, and embedded in paraffin at the
Biobank of Andalusia Public Health System. Tissue sections were
cut and processed for haematoxylin and eosin staining or for
immunohistochemistry staining with Anti-Human Smooth Muscle
Actin (IR611; Dako), Ms Anti-Human Cytokeratin Clone AE1/AE3
(IR053; Dako), and Rb Anti-Human Glial Fibrillary Acidic Protein
(IR 624; Dako). Species-specific secondary antibodies conjugated
with peroxidase were used (EnVision Flex/HPR SM802; Dako). Im-
munohistochemistry staining images were quantified measuring
the area that was positive for the signal of the antibody. For each
staining, 10 images were quantified using Image J, averaged, and
tested statistically using t test.
Derivation of Bmal12/2 mESCs
Single-guide RNA sequences (Oligo 1: 59-CACCGAACCGGA-
GAGTAGGTCGGT-39, Oligo 2: 59-AAACACCGACCTACTCTCCGGTTC-39)
were designed using CRISPR design tool and cloned into PX458
plasmid (Ran et al, 2013) upon testing with surveyor mutation
detection kit (IDT). JM8 mESCs were transfected using lipofect-
amine 2000 (Thermo Fisher Scientific). Cells positive for GFP
expression were sorted using flow cytometry and plated at serial
dilutions to obtain isolated clonal colonies. DNA of 12 genetic
clones was PCR-amplified (59-TCTGCCTGGCTTATTCTTCC-39 and
59-AGTGCTGCTGGCCATTTAAG-39) and sequenced upon pGEM-T
(Promega) cloning. Four genetic clones showed mutations in both
alleles and in the one containing mutation that produced a shorter
version of Bmal1 protein was further characterized by RT-qPCR and
Western blot.
RT-qPCR and immunofluorescence
RNA was isolated using Trizol reagent (Thermo Fisher Scientific),
reverse transcribed using RevertAid Frist Strand cDNA Synthesis kit
(Thermo Fisher Scientific), and analysed by SYBRG real-time PCR
using GoTaq qPCR Master Mix (Promega). Primers used are provided
in Table S1.
Immunofluorescence analysis of mESCs colonies was carried out
as described previously (Landeira et al, 2015). Briefly, the cells were
fixed for 20 min in 2% paraformaldehyde, permeabilized 5 min in
0.4% Triton-X100, and blocked for 30 min in phosphate buffer saline
supplemented with 0.05% Tween 20, 2.5% bovine serum albumin,
and 10% goat serum. Primary antibodies used were Ms anti-Oct4
(611202; BD Biosciences), Rb anti-Nanog (RCAB002P-F; Cosmo Bio),
and Ms anti-Nestin (MAB353; Merck). Secondary antibodies used
were goat antimouse Alexa Fluor 488 (A-11001; Thermo Fisher
Scientific) and goat antirabbit Alexa Fluor 555 (A-21429; Thermo
Fisher Scientific). Slides were imaged by widefield fluorescence
microscope Zeiss Axio Imager and images were analysed using
Image J.
Cell fractionation and Western blots
Separation of cytosol and nucleus fractions was carried out by
resuspending 4 × 106 cells in 80 μl of cell lysis buffer, pH 7.9 (10 mM
Hepes, 10 mM KCl, 100 μM EGTA, 100 μM EDTA, and freshly added
1 mM DTT, 1 mM PMSF, and protease inhibitors). After 15-min in-
cubation on ice, 10 μl of cell lysis buffer with NP40 10% was added.
Cytoplasmic supernatant was recovered by spinning at 16,200g, 4°C
for 5 min. Pelleted nuclei were resuspended in 80 μl of nuclear lysis
buffer (20 mM Hepes, 400 mM NaCl, 1 mM EGTA, 1 mM EDTA, and
freshly added 1 mM DTT, 0.5 mM PMSF, and protease inhibitors).
Soluble nuclear supernatant was recovered by spinning at
13,000 rpm, 4°C for 5 min. Cytoplasmic and nuclear fractions were
mixed with equal volumes of 2× Laemmli loading buffer. In ex-
periments where cell fractionation was not carried out, Western
blots were carried out in whole-cell extracts lysed with 2× Laemmli
loading buffer and using standard procedures. The following pri-
mary antibodies were used: Ms anti-Oct4 (611202; BD Biosciences),
Rb anti-Nanog (RCAB002P-F; Cosmo Bio), Gt anti–Lamin B (SC-6216;
Santa Cruz), Ms anti-ActB (A4700; Sigma-Aldrich), Rb anti-Bmal1
(ab93806; Abcam), Ms anti-MAP Kinase 2 (05-157; Merck), and Rb anti-
Ezh2 (C15410039; Diagenode). Secondary species-specific antibodies
conjugated to horseradish peroxidase were used: anti-rabbit-HRP
analysis of pluripotency markers Nanog, Oct4, and Rex1 in Bmal1−/− (clone #G10) and JM8 wild-type mESCs by RT-qPCR. Expression was normalized toHmbs and Ywhaz.
(H) Western blot analysis of Nanog protein using whole-cell extracts of Bmal1−/− (clone #G10) and wild-type mESCs. Lamin B provide a loading control. (I) Microscopic
images of gastruloids generated at day five by Bmal1−/− (clone #G10) and JM8 wild-type mESCs. Scale bar is 100 μm. (J)mRNA expression of ectoderm (blue)-, endoderm
(green)-, and mesoderm (red)-specific genes on day five of gastruloid differentiation as measured by RT-qPCR in JM8 wild-type and Bmal1−/− (clone #G10) mESCs.
Expression was normalized to Hmbs and Ywhaz. Fold change of Bmal1−/− #G10 relative to wild-type is represented. (B, C, D, E, G, J) Mean and SEM of three independent
experiments are shown in (B, C, D, E, G, J). Asterisks (*) indicate significant difference (T-student P < 0.05).
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(NA931; GE Healthcare), anti-mouse-HRP (NA931; GE Healthcare), and
anti-goat-HRP (ab97110; Abcam). Clarity Western ECL reagents
(Bio-Rad) was used for detection.
mRNA-seq and bioinformatic analysis
Total RNA of JM8 wild-type and Bmal1−/−mESCs growing in the 2i +
LIF medium was isolated using Trizol (Thermo Fisher Scientific), and
mRNA library preparation was carried out using TruSeq Stranded
mRNA kit (Illumina). 30 million 75-bp paired end reads were ana-
lysed per sample. Two biological replicates were carried out for
each cell line. Library preparation and Illumina sequencing was
carried out at National Center for Genomic Analysis-Center for
Genomic Regulation (CNAG-CRG). Raw FASTQ files were quality
filtered and aligned to the mouse genome (version mm9) using
STAR 2.5.2 (Dobin & Gingeras, 2015). Gene expression was nor-
malized with trimmedmean of M values (Robinson & Oshlack, 2010)
implemented in NOISeq R package (Tarazona et al, 2015). Differ-
ential expression analysis was performed with DESeq2 package
(Love et al, 2014). MA plot was generated with edgeR (McCarthy et al,
2012) and heat maps were generated with pheatmap package.
mRNA of deregulated genes (log2 fold change greater than 1 or
smaller than −1 and adjusted P-value < 0.05) were used as input
gene lists in DAVID bioinformatic gene enrichment analysis. List of
differentially expressed genes is provided in Table S1.
Single-cell RNA expression of Bmal1 and Oct4 in developing
blastocysts was extracted from published data (Deng et al, 2014).
The cells were classified by the level of expression of Oct4 in four
quartile groups (Oct4 low correspond to bottom quartile and Oct4
high corresponds to top quartile), and average expression of Bmal1
was plotted.
Data access
Datasets are available at GEO-NCBI with accession number GSE134884
(https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE134884).
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Supplementary Information is available at https://doi.org/10.26508/lsa.
201900535.
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